Brief: Denali Therapeutics Q2 Basic EPS USD -0.72
11/08/2025 21:02
Aug 11 (Reuters) - Denali Therapeutics Q2 net income USD -124.119 million. Q2 operating income USD -134.963 million Q2 operating expenses USD 134.963 million
Recent news on Denali Therapeutics
See all newsDenali Therapeutics Inc. reports results for the quarter ended June 30 - Earnings Summary
Denali Therapeutics Q2 net loss widens as AVLAYAH launch costs rise
Biogen's Alzheimer's drug lowers toxic protein, but results were mixed
U.S. STOCKS ON THE MOVE-Sweetgreen, Dell Technologies, Peloton Interactive
U.S. STOCKS ON THE MOVE-IMAX, Novo Nordisk, PC makers